Synaptogenix (SNPX) Stock Chart & Stock Price History $9.70 -0.69 (-6.60%) As of 07/15/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Synaptogenix Stock Price Performance The Synaptogenix (SNPX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 118.36%, with a year-to-date return of 179.39%. In the past month, the stock has increased 127.05%, reflecting recent market activity. As of the latest close, Synaptogenix traded at $10.38 with a market cap of $14.43 million and volume of 602,481 shares. Receive SNPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+36.17%1 Month Performance+127.05%3 Month Performance+333.78%Year-To-Date Performance+179.39%1 Year Performance+118.36% SNPX Stock Chart for Wednesday, July, 16, 2025 SNPX Chart by TradingView Synaptogenix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/16/2025$10.38$9.70-6.60%$10.60$8.56420,936 shs$13.48 million07/15/2025$8.99$10.38+15.46%$11.40$9.00602,481 shs$14.43 million07/14/2025$8.99$8.99$9.00$7.60998,620 shs$12.50 million07/11/2025$7.12$7.12$7.99$6.96197,738 shs$9.90 million07/10/2025$8.20$7.12-13.17%$7.99$6.96197,738 shs$9.90 million07/09/2025$7.63$8.20+7.47%$8.74$7.32629,144 shs$11.40 million07/08/2025$8.50$7.63-10.24%$8.53$7.15248,682 shs$10.61 million07/07/2025$8.50$8.50$8.53$7.60140,224 shs$11.82 million07/04/2025$8.08$8.50+5.20%$8.53$7.60140,224 shs$11.82 million07/03/2025$8.35$8.08-3.23%$8.94$7.51342,231 shs$11.23 million Get the Latest News and Ratings for SNPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. 07/02/2025$7.85$8.35+6.37%$8.61$6.10725,327 shs$11.61 million07/01/2025$7.85$7.85$7.85$5.63993,594 shs$10.91 million06/30/2025$6.05$7.85+29.75%$7.85$5.63993,594 shs$10.91 million06/27/2025$4.90$6.05+23.47%$6.19$4.53734,871 shs$8.41 million06/26/2025$3.77$4.90+29.97%$5.43$3.68668,888 shs$6.81 million06/25/2025$4.00$3.77-5.75%$3.94$3.50239,383 shs$5.24 million06/24/2025$3.58$4.00+11.73%$4.20$3.50217,510 shs$5.56 million06/23/2025$4.30$3.58-16.74%$4.28$3.25263,439 shs$4.98 million06/20/2025$4.10$4.30+4.88%$4.44$3.90219,371 shs$5.98 million06/19/2025$4.10$4.10$4.29$3.80126,483 shs$5.70 million06/18/2025$3.92$4.10+4.59%$4.29$3.80126,483 shs$5.70 million06/17/2025$4.27$3.92-8.20%$4.22$3.77209,536 shs$5.45 million06/16/2025$3.71$4.27+15.09%$4.51$3.90247,183 shs$5.94 million Related Companies Eagle Pharmaceuticals Stock Price Chart Grace Therapeutics Stock Price Chart Exicure Stock Price Chart Acrivon Therapeutics Stock Price Chart Artiva Biotherapeutics Stock Price Chart Eliem Therapeutics Stock Price Chart Mersana Therapeutics Stock Price Chart Barinthus Biotherapeutics Stock Price Chart Shattuck Labs Stock Price Chart Iterum Therapeutics Stock Price Chart Receive SNPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SNPX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synaptogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synaptogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
